Pharmaceuticals

Curanex Pharmaceuticals

Curanex Pharmaceuticals released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 0, actual EPS USD -0.1083

Curanex Pharmaceuticals released FY2025 Annual Earnings on March 30, 2026 (EST), with actual revenue of USD 0 and EPS of USD -0.17

Curanex Pharmaceuticals released FY2025 Q3 earnings on November 17, 2025, EST with actual revenue USD 0 and EPS USD -0.0372

Curanex Pharmaceuticals released FY2025 9 Months earnings on November 17 (EST), actual revenue USD 0, actual EPS USD -0.0455

Curanex Pharmaceuticals Inc. issued 28,312 shares to Song Xiaohong after IPO

Curanex Pharmaceuticals released FY2025 Q2 earnings on September 9, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0025

Curanex Pharmaceuticals released FY2025 Semi-Annual earnings on September 9 (EST), actual revenue USD 0, actual EPS USD -0.0082

Curanex Pharmaceuticals released FY2024 Q2 earnings on September 9, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.02

Curanex Pharmaceuticals Inc. released FY2024 Q1 earnings on July 1, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.1336

Curanex Pharmaceuticals Inc. released FY2025 Q1 earnings on July 1 (EST) with actual revenue of USD 0 and EPS of USD -0.0057

Curanex Pharmaceuticals Inc. released FY2024 earnings on February 14 (EST) with actual revenue of USD 0 and EPS of USD -0.0272

Curanex Pharmaceuticals released FY2024 Q4 earnings on February 14 (EST), actual revenue USD 0, actual EPS USD -0.0036

Curanex Pharmaceuticals Inc. released FY2023 Q4 earnings on February 14, 2025 (EST), actual revenue USD 0, actual EPS USD -0.0211

Curanex Pharmaceuticals Inc released FY2023 Annual Earnings on February 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.0319

Curanex Pharmaceuticals released FY2024 Q3 earnings on November 1, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0379

Curanex Pharmaceuticals released FY2024 9 Months Earnings on November 1, 2024 (EST), with actual revenue of USD 0 and EPS of USD -0.19

Curanex Pharmaceuticals Inc released FY2023 Q3 earnings on November 1, 2024 (EST) with actual revenue of USD 0 and EPS of USD 0

Curanex Pharmaceuticals Inc. released FY2023 9 Months Earnings on November 1, 2024 (EST) with actual revenue of USD 0 and EPS of USD -0.0108

Curanex Pharmaceuticals Inc. released FY2023 Semi-Annual earnings on October 16 (EST), actual revenue USD 0, actual EPS USD -0.0109

Curanex Pharmaceuticals Inc released FY2023 Q1 earnings on October 16 (EST), actual revenue USD 0, actual EPS USD -0.0054

Fusemachines

Erayak Power Solution

Smart Powerr

Sky Quarry

Cue BioPharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

ZeZentalis Pharma

XCF Global

Rackspace Tech

U Power

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Curanex Pharmaceuticals(CURX.US)

Curanex Pharmaceuticals Stock Performance Chart